Journal article
Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study
Abstract
Multiparametric assays for risk stratification are widely used in the management of both node negative and node positive hormone receptor positive invasive breast cancer. Recent data from multiple sources suggests that different tests may provide different risk estimates at the individual patient level. The TEAM pathology study consists of 3284 postmenopausal ER+ve breast cancers treated with endocrine therapy Using genes comprising the …
Authors
Bartlett JMS; Bayani J; Kornaga E; Xu K; Pond GR; Piper T; Mallon E; Yao CQ; Boutros PC; Hasenburg A
Journal
npj Breast Cancer, Vol. 7, No. 1,
Publisher
Springer Nature
DOI
10.1038/s41523-021-00297-7
ISSN
2374-4677